BMJ backtracks on Foscan

The British Medical Journal admitted making mistakes in publishing an article on Foscan, a photodynamic therapy to treat cancer from Scotia (LSE:SOH). The journal published data showing that Foscan caused partial thickness burns to the skin following treatment in 14 patients. SOH had pointed out that this was data from 14 patients out of 800 and that the data already had been given to regulatory authorities (see BioCentury, May 8). ...